Progress in the therapeutic inhibition of Cdc42 signalling
Sign Up to like & getrecommendations! Published in 2021 at "Biochemical Society Transactions"
DOI: 10.1042/bst20210112
Abstract: Cdc42 is a member of the Rho family of small GTPases and a key regulator of the actin cytoskeleton, controlling cell motility, polarity and cell cycle progression. It signals downstream of the master regulator Ras… read more here.
Keywords: cdc42; therapeutic inhibition; cell; progress therapeutic ... See more keywords
Recent progress in therapeutic strategies and biomimetic nanomedicines based on neutrophils for inflammation treatment.
Sign Up to like & getrecommendations! Published in 2023 at "Nanomedicine"
DOI: 10.2217/nnm-2022-0211
Abstract: Inflammation is a defensive response that helps repair and restore damaged tissue by activating immune and nonimmune cells against pathogens. However, inflammation may cause chronic disease if it persists for a long time. Neutrophils recruit immediately to… read more here.
Keywords: recent progress; inflammation; therapeutic strategies; progress therapeutic ... See more keywords
Research progress on the therapeutic effects of polysaccharides on non-alcoholic fatty liver diseases
Sign Up to like & getrecommendations! Published in 2023 at "Frontiers in Nutrition"
DOI: 10.3389/fnut.2023.1107551
Abstract: Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease and is a leading cause of cirrhosis and hepatocellular carcinoma. Due to its complex pathophysiology, there is currently no approved therapy. Polysaccharide,… read more here.
Keywords: alcoholic fatty; progress therapeutic; non alcoholic; fatty liver ... See more keywords